Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Age-Related Macular Degeneration Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments - Research and Markets

Research and Markets
Posted on: 02 Aug 17

The "Age-Related Macular Degeneration Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments" report has been added to Research and Markets' offering.

The global age-related macular degeneration market accounted for revenue of $5,335.7 million in 2015, and it is expected to grow at a CAGR of 7.6% during 2016 - 2022.

Among the various types, the wet AMD segment is expected to witness the faster growth during the forecast period.

The global age-related macular degeneration market is growing at a significant rate, due to growing geriatric population, and increasing prevalence of age-related macular degeneration.

In addition, increasing prevalence of lifestyle associated diseases such as obesity and hypertension, increasing healthcare expenditure and increasing pipeline drugs for AMD are also driving the growth of the global age-related macular degeneration market.

Age-related macular degeneration (AMD) is an acquired retinal disorder indicated by fundus changes. It is one of the most common forms of visual impairment in the geriatric population.

It is a deterioration or degeneration of macular, leading to vision loss among people aged 60 years and above. The macula is a small part of retina responsible of sharpness and central vision.

Key Topics Covered:

1. Research Scope And Methodology

2. Executive Summary

3. Market Outlook

4. Drug Approval Process In The U.S. And Eu

5. Global Age-Related Macular Degeneration Market Size And Forecast (2012-2022)

6. Global Age-Related Macular Degeneration Market, By Type

7. Global Age-Related Macular Degeneration Market, By Geography

8. Competitive Positioning Analysis

9 Key Company Profiles

  • Novartis Ag
  • F. Hoffmann-La Roche Ltd
  • Bayer Ag.
  • Regeneron Pharmaceutical, Inc.
  • Acucela
  • Ophthotech Corporation
  • Neurotech Pharmaceuticals, Inc.
  • Glaxosmithkline Plc
  • Stemcells Inc.
  • Alimera Sciences, Inc.

10. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/3fqkl5/agerelated

View source version on businesswire.com: http://www.businesswire.com/news/home/20170802005684/en/

Business Wire
www.businesswire.com

Last updated on: 02/08/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.